Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
She'd previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles.
We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of trial diversity can have when presenting information to patients and providers, and why medical affairs has the skillset to make change.
Don’t miss an episode and subscribe to the newsletter:
✉️ pharmasessions.substack.com
What You’ll Learn:
05:50:00 How to assess the primary endpoint of clinical trials.
06:54:00 The demographics of patients in clinical trials.
11:34:00 How can we think differently about who we are engaging in clinical trials?
16:32:00 Clinical Trial Diversity Workstream.
21:50:00 How to measure patient representation in clinical trials
24:50:00 How to ask about clinical trial options?
27:11:00 Prioritization and budgets
Resources:
Jonathan Kaskey
👤 LinkedIn: www.linkedin.com/in/jonkaskey
🔗 Website: www.pharmasessions.substack.com
✉️ Email: pharmasessions@substack.com
🐤 Twitter: @PharmaSessions
🎥 YouTube: @PharmaSessions
Camille Pope
👤 LinkedIn: https://www.linkedin.com/in/camille-pope/
Spotify: https://open.spotify.com/episode/2CqK5Apvgnm6B2EGTI8sHN?si=1a45fe814913417f
Apple: https://podcasts.apple.com/us/podcast/increasing-clinical-trial-diversity-with-camille-pope/id1641549065?i=1000605399386
Pharma Sessions is hosted by Jonathan Kaskey
Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/
Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com